CSF2 and neoplasm: Thus, we assume that in our experiments, the variability in M-MDSC frequencies by day 15 and 24 after LRAST pretreatment (w/o RB6-8C5) results from a GM-CSF-driven expansion and redistribution, e.g., into tumor tissue.